STOCK MARKET BSE NSE

India engaged with US entities for procurement of COVID-19 vaccines: MEA

Hit by a devastating second wave of the coronavirus pandemic, India has been focusing on ramping up domestic production of COVID-19 vaccines as well their procurement from abroad.

Published: 20th May 2021 09:38 PM  |   Last Updated: 20th May 2021 09:38 PM   |  A+A-

Covishield vaccine (L) and Covaxin (R)

Covishield vaccine (L) and Covaxin (R) (Photos | EPS)

By PTI

NEW DELHI: India is engaged with American entities for procurement of COVID-19 vaccines from the US and their possible manufacturing in the country subsequently, the Ministry of External Affairs said on Thursday.

Hit by a devastating second wave of the coronavirus pandemic, India has been focusing on ramping up domestic production of COVID-19 vaccines as well their procurement from abroad.

"We remain engaged with US entities on the prospect of procuring vaccines from the US and also perhaps manufacturing them in India subsequently," Spokesperson in the Ministry of External Affairs Arindam Bagchi said at a media briefing.

"This would augment our vaccine availability. Once this is available, whether it is through procurement or subsequent manufacturing," he said.

Bagchi also said that India has noted the announcement by the US on supplying COVID-19 vaccines to some countries.

The US announced earlier this week that it will share an additional 20 million coronavirus vaccine doses with other countries in addition to the 60 million it has already committed.

"We have, of course, noted the recent announcement by the US government of its intention to make some vaccines available to some other countries," Bagchi said.

He said all vaccines to be procured from abroad would need to be compliant with India's regulatory guidelines.

"I would like to emphasise that all vaccines that may be procured from abroad would need to be as per our regulatory guidelines.

I understand that the US has also indicated that any vaccines it sends abroad would be after obtaining FDA (Food and Drug Administration) clearance for product quality," he said.

Recently, Charge D'Affaires of the US embassy Daniel B Smith said the US was looking at joint production of Johnson and Johnson's COVID-19 vaccines in India and ways to help manufacturers like the Serum Institute of India (SII) to boost production.

As India was facing a rapid increase in coronavirus infections, the US deployed six planeloads of life-saving supplies in support of the country's fight against the pandemic.

The US government's assistance to India is estimated at about USD 100 million.

To a separate question, Bagchi said a large number of countries have expressed solidarity with India in its fight against the second wave of the pandemic.

He said around 40 countries have sent medical equipment and other supplies.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp